Why Brean's Jason Wittes Is Watching Osir Therapeutics
October 01, 2015 at 09:36 AM EDT
Shares of Osiris Therapeutics, Inc. (NASDAQ: OSIR) have increased by 19.62 percent year-to-date, reaching a high of $22.64 on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.